Translate
Preveceutical Medical Inc
About
Preveceutical Medical Inc (CN:PREV) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 1 2026
PreveCeutical Adopts Semi-Annual Financial Reporting
Mar 30 2026
PreveCeutical Medical Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director
Feb 25 2026
PreveCeutical Announces Canadian Patent Office Allowance of Innovative Pain Therapy Technology
Feb 9 2026
PreveCeutical Announces Filing of Patent for Delivery of CNS-Active Agents
Dec 4 2025
PreveCeutical Announces Grant of Patent for Innovative Pain Therapy Technology
Recent Videos
Revolutionary Non-Addictive Painkiller Stronger Than Opioids
Mar 25, 2026
PreveCeutical advances drug delivery tech with Sol-Gel platform, eyes multi-asset spinouts
Mar 25, 2026
Integrity-Driven Healthcare Tech | SoRI 2025 Issuer Update (CSE:PREV)
Jun 05, 2025
PreveCeutical's CEO and Chairman, Stephen Van Deventer, New to the Street Interview.
Sep 28, 2023
Financials
Revenue
CA$0
Market Cap
CA$11.74 M
EPS
-0.01